PlainRecalls
FDA Drug Moderate Class II Terminated

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Reported: March 29, 2017 Initiated: March 6, 2017 #D-0605-2017

Product Description

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Reason for Recall

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Details

Units Affected
9561 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 9561 bottles.
Why was this product recalled?
Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 29, 2017. Severity: Moderate. Recall number: D-0605-2017.